使用电刺激人工智能经颅刺激的青光眼康复(GREAT)研究:联合知觉学习与经颅电刺激增强视力的随机对照试验方案
GREAT项目采用三臂、双盲、随机、优效性对照设计,将青光眼患者按1:1:1随机分配至真实知觉学习联合真实经颅电刺激组、真实知觉学习联合假经颅电刺激组及安慰剂知觉学习联合假经颅电刺激组,每名参与者每区块接受10次干预(每次约1小时),共三个区块。主要结局为Humphrey视野分析仪测量的24-2视野平均偏差,并在基线、中期1、中期2、干预后、干预后1个月及干预后2个月共六个时间点进行评估。
要点
- GREAT是首个评估知觉学习与经颅电刺激联合用于青光眼康复的研究。
- 三臂双盲随机优效性设计,按1:1:1分配至真实联合、真实知觉学习加假刺激、双假刺激组。
- 主要结局为Humphrey视野分析仪24-2视野平均偏差,共六个评估时间点。
核心结论
- GREAT项目旨在探究联合知觉学习与经颅电刺激是否比单独使用任一方法更有效地最大化青光眼患者的视功能。
- 研究将全面评估这些干预对视野、神经活动、生物标志物、移动能力、心理健康、跌倒恐惧和生活质量等多方面指标的影响。
研究设计与样本
- 三臂、双盲、随机、优效性对照试验,参与者按1:1:1比例随机分配至三组。
- 三组分别接受:真实知觉学习联合真实经颅电刺激、真实知觉学习联合假经颅电刺激、安慰剂知觉学习联合假经颅电刺激。
- 每名参与者每区块接受10次干预(每次约1小时),共三个区块;评估在基线、中期1、中期2、干预后、干预后1个月及干预后2个月共六个时间点进行。
主要发现
- 主要结局为Humphrey视野分析仪测量的24-2视野平均偏差。
- 次要结局包括超阈值视野检测率、平衡与步态功能、电生理与生物学反应。
- 研究还探讨干预前后神经递质代谢、生物标志物、自评生活质量及心理状态的变化。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Glaucoma patients with irreversible visual field loss often experience decreased quality of life, impaired mobility, and mental health challenges. Perceptual learning (PL) and transcranial electrical stimulation (tES) have emerged as promising interventions for vision rehabilitation, showing potential in restoring residual visual functions. The Glaucoma Rehabilitation using ElectricAI Transcranial stimulation (GREAT) project aims to investigate whether combining PL and tES is more effective than using either method alone in maximizing the visual function of glaucoma patients. Additionally, the study will assess the impact of these interventions on brain neural activity, blood biomarkers, mobility, mental health, quality of life, and fear of falling. METHODS: The study employs a three-arm, double-blind, randomized, superiority-controlled design. Participants are randomly allocated in a 1:1:1 ratio to one of three groups receiving: (1) real PL and real tES, (2) real PL and sham tES, and (3) placebo PL and sham tES. Each participant undergoes 10 sessions per block (~ 1 h each), with a total of three blocks. Assessments are conducted at six time points: baseline, interim 1, interim 2, post-intervention, 1-month post-intervention, and 2-month post-intervention. The primary outcome is the mean deviation of the 24-2 visual field measured by the Humphrey visual field analyzer. Secondary outcomes include detection rate in the suprathreshold visual field, balance and gait functions, and electrophysiological and biological responses. This study also investigates changes in neurotransmitter metabolism, biomarkers, self-perceived quality of life, and psychological status before and after the intervention. DISCUSSION: The GREAT project is the first study to assess the effectiveness of PL and tES in the rehabilitation of glaucoma. Our findings will offer comprehensive assessments of the impact of these treatments on a wide range of brain and vision-related metrics including visual field, neural activity, biomarkers, mobility, mental health, fear of falling, and quality of life. TRIAL REGISTRATION: ClinicalTrials.gov NCT05874258 . Registered on May 15, 2023.
引用
- Jia S, Mei X, Chen L, et al. Glaucoma Rehabilitation using ElectricAI Transcranial Stimulation (GREAT)-study protocol for randomized controlled trial using combined perceptual learning and transcranial electrical stimulation for vision enhancement. Trials. 2024. PMID: 39039582. doi:10.1186/s13063-024-08314-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。